• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

PAX6-ZEB2 轴通过 PI3K/AKT 信号通路促进非小细胞肺癌的转移和顺铂耐药性。

The PAX6-ZEB2 axis promotes metastasis and cisplatin resistance in non-small cell lung cancer through PI3K/AKT signaling.

机构信息

Clinical Laboratory, The First Affiliated Hospital of Chengdu Medical College, Chengdu, Sichuan, 610500, China.

出版信息

Cell Death Dis. 2019 Apr 25;10(5):349. doi: 10.1038/s41419-019-1591-4.

DOI:10.1038/s41419-019-1591-4
PMID:31024010
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6483988/
Abstract

Paired-box 6 (PAX6) is an important transcription factor required for the function of human neuroectodermal epithelial tissues. Previous studies have suggested that it is also expressed in several types of tumors and has an oncogenic role. However, little is known about its role in non-small cell lung cancer (NSCLC). Here, we found that PAX6 expression levels were upregulated in human lung cancer tissues and correlated with poor clinical outcomes. PAX6 overexpression significantly promoted NSCLC epithelial-to-mesenchymal transition (EMT) and metastasis, whereas its knockdown inhibited these processes. PAX6 is commonly correlated with EMT-mediated stem cell transformation, thereby inducing cisplatin resistance. Using the RT Profiler PCR Array, we found that WNT5A, EGFR, and ZEB2 were differentially regulated in response to PAX6 modulation. In addition, PAX6 directly bound to the promoter region of ZEB2. ZEB2 knockdown significantly reduced the expression and function of PAX6. ZEB2 was upregulated upon PAX6 overexpression and downregulated upon PAX6 knockdown, whereas E-cadherin expression negatively correlated with PAX6 levels. Moreover, p-PI3K and p-AKT were significantly enhanced by PAX6, which was reversed by the addition of the PI3K-AKT inhibitor, LY294002. These data suggest that PAX6 can mediate E-cadherin downregulation through the PI3K/AKT signaling pathway by directly binding the promoter region of ZEB2, thereby mediating cell migration, stem cell transformation, and cisplatin resistance; and ultimately, affecting survival in NSCLC patients.

摘要

配对盒基因 6(PAX6)是人类神经外胚层上皮组织功能所必需的重要转录因子。先前的研究表明,它也在几种类型的肿瘤中表达,并具有致癌作用。然而,关于它在非小细胞肺癌(NSCLC)中的作用知之甚少。在这里,我们发现 PAX6 在人类肺癌组织中的表达水平上调,并与不良的临床结局相关。PAX6 过表达显著促进 NSCLC 上皮间质转化(EMT)和转移,而其敲低则抑制这些过程。PAX6 通常与 EMT 介导的干细胞转化相关,从而诱导顺铂耐药。使用 RT Profiler PCR 阵列,我们发现 WNT5A、EGFR 和 ZEB2 对 PAX6 调节的反应存在差异调节。此外,PAX6 直接与 ZEB2 启动子区域结合。ZEB2 敲低显著降低了 PAX6 的表达和功能。PAX6 过表达上调 ZEB2,而 PAX6 敲低下调 ZEB2,而 E-钙粘蛋白表达与 PAX6 水平呈负相关。此外,p-PI3K 和 p-AKT 被 PAX6 显著增强,PI3K-AKT 抑制剂 LY294002 的加入可逆转这一增强。这些数据表明,PAX6 可以通过直接结合 ZEB2 的启动子区域,通过 PI3K/AKT 信号通路介导 E-钙粘蛋白下调,从而介导细胞迁移、干细胞转化和顺铂耐药;最终影响 NSCLC 患者的生存。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/931e/6483988/3226cf09abd8/41419_2019_1591_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/931e/6483988/b7064d886b2f/41419_2019_1591_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/931e/6483988/3faf147f7aab/41419_2019_1591_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/931e/6483988/86bfe57e3179/41419_2019_1591_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/931e/6483988/c9ca35aeb91d/41419_2019_1591_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/931e/6483988/d179da9034d7/41419_2019_1591_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/931e/6483988/3226cf09abd8/41419_2019_1591_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/931e/6483988/b7064d886b2f/41419_2019_1591_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/931e/6483988/3faf147f7aab/41419_2019_1591_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/931e/6483988/86bfe57e3179/41419_2019_1591_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/931e/6483988/c9ca35aeb91d/41419_2019_1591_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/931e/6483988/d179da9034d7/41419_2019_1591_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/931e/6483988/3226cf09abd8/41419_2019_1591_Fig6_HTML.jpg

相似文献

1
The PAX6-ZEB2 axis promotes metastasis and cisplatin resistance in non-small cell lung cancer through PI3K/AKT signaling.PAX6-ZEB2 轴通过 PI3K/AKT 信号通路促进非小细胞肺癌的转移和顺铂耐药性。
Cell Death Dis. 2019 Apr 25;10(5):349. doi: 10.1038/s41419-019-1591-4.
2
Long non-coding RNA XIST promotes TGF-β-induced epithelial-mesenchymal transition by regulating miR-367/141-ZEB2 axis in non-small-cell lung cancer.长链非编码 RNA XIST 通过调控 miR-367/141-ZEB2 轴促进 TGF-β诱导的非小细胞肺癌上皮-间质转化。
Cancer Lett. 2018 Apr 1;418:185-195. doi: 10.1016/j.canlet.2018.01.036. Epub 2018 Jan 17.
3
Long non-coding RNA ZEB2-AS1 promotes the proliferation, metastasis and epithelial mesenchymal transition in triple-negative breast cancer by epigenetically activating ZEB2.长链非编码 RNA ZEB2-AS1 通过表观遗传激活 ZEB2 促进三阴性乳腺癌的增殖、转移和上皮间质转化。
J Cell Mol Med. 2019 May;23(5):3271-3279. doi: 10.1111/jcmm.14213. Epub 2019 Mar 1.
4
Neogenin-1 Promotes Cell Proliferation, Motility, and Adhesion by Up-Regulation of Zinc Finger E-Box Binding Homeobox 1 Via Activating the Rac1/PI3K/AKT Pathway in Gastric Cancer Cells.新生蛋白-1通过激活Rac1/PI3K/AKT信号通路上调锌指E盒结合同源框1,从而促进胃癌细胞的增殖、迁移和黏附。
Cell Physiol Biochem. 2018;48(4):1457-1467. doi: 10.1159/000492255. Epub 2018 Jul 31.
5
BENC-511, a novel PI3K inhibitor, suppresses metastasis of non-small cell lung cancer cells by modulating β-catenin/ZEB1 regulatory loop.BENC-511,一种新型的 PI3K 抑制剂,通过调节 β-catenin/ZEB1 调控环抑制非小细胞肺癌细胞的转移。
Chem Biol Interact. 2018 Oct 1;294:18-27. doi: 10.1016/j.cbi.2018.08.010. Epub 2018 Aug 17.
6
FAM83D promotes epithelial-mesenchymal transition, invasion and cisplatin resistance through regulating the AKT/mTOR pathway in non-small-cell lung cancer.FAM83D 通过调控非小细胞肺癌中的 AKT/mTOR 通路促进上皮间质转化、侵袭和顺铂耐药。
Cell Oncol (Dordr). 2020 Jun;43(3):395-407. doi: 10.1007/s13402-020-00494-9. Epub 2020 Jan 31.
7
Src promotes EGF-induced epithelial-to-mesenchymal transition and migration in gastric cancer cells by upregulating ZEB1 and ZEB2 through AKT.Src 通过激活 AKT 上调 ZEB1 和 ZEB2 促进表皮生长因子诱导的胃癌细胞上皮间质转化和迁移。
Cell Biol Int. 2018 Mar;42(3):294-302. doi: 10.1002/cbin.10894. Epub 2017 Nov 15.
8
CNTN-1 Enhances Chemoresistance in Human Lung Adenocarcinoma Through Induction of Epithelial-Mesenchymal Transition by Targeting the PI3K/Akt Pathway.CNTN-1通过靶向PI3K/Akt通路诱导上皮-间质转化增强人肺腺癌的化疗耐药性。
Cell Physiol Biochem. 2017;43(2):465-480. doi: 10.1159/000480473. Epub 2017 Sep 1.
9
HPIP promotes epithelial-mesenchymal transition and cisplatin resistance in ovarian cancer cells through PI3K/AKT pathway activation.HPIP通过激活PI3K/AKT信号通路促进卵巢癌细胞上皮-间质转化和顺铂耐药。
Cell Oncol (Dordr). 2017 Apr;40(2):133-144. doi: 10.1007/s13402-016-0308-2. Epub 2016 Dec 30.
10
COX-2 potentiates cisplatin resistance of non-small cell lung cancer cells by promoting EMT in an AKT signaling pathway-dependent manner.COX-2 通过激活 AKT 信号通路促进 EMT 从而增强非小细胞肺癌细胞对顺铂的耐药性。
Eur Rev Med Pharmacol Sci. 2019 May;23(9):3838-3846. doi: 10.26355/eurrev_201905_17811.

引用本文的文献

1
GPX3 promotes cisplatin resistance in TNBC by manipulating ROS-TGFB1-ZEB2.GPX3通过调控ROS-TGFB1-ZEB2促进三阴性乳腺癌对顺铂的耐药性。
Cell Commun Signal. 2025 Jul 25;23(1):355. doi: 10.1186/s12964-025-02356-z.
2
ZEB2 upregulation modulates the polarization of TAMs toward the immunosuppressive state in EGFR-TKI-resistant NSCLC.ZEB2上调可调节表皮生长因子受体酪氨酸激酶抑制剂(EGFR-TKI)耐药的非小细胞肺癌(NSCLC)中肿瘤相关巨噬细胞(TAMs)向免疫抑制状态的极化。
Cancer Drug Resist. 2025 May 29;8:25. doi: 10.20517/cdr.2024.206. eCollection 2025.
3
PAX Family, Master Regulator in Cancer.

本文引用的文献

1
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.全球癌症统计数据 2018:GLOBOCAN 对全球 185 个国家/地区 36 种癌症的发病率和死亡率的估计。
CA Cancer J Clin. 2018 Nov;68(6):394-424. doi: 10.3322/caac.21492. Epub 2018 Sep 12.
2
Transcription factor PAX6 as a novel prognostic factor and putative tumour suppressor in non-small cell lung cancer.转录因子 PAX6 作为非小细胞肺癌的新型预后因子和潜在的肿瘤抑制因子。
Sci Rep. 2018 Mar 22;8(1):5059. doi: 10.1038/s41598-018-23417-z.
3
Src promotes EGF-induced epithelial-to-mesenchymal transition and migration in gastric cancer cells by upregulating ZEB1 and ZEB2 through AKT.
PAX家族,癌症中的主调控因子。
Diagnostics (Basel). 2025 Jun 3;15(11):1420. doi: 10.3390/diagnostics15111420.
4
Aegle marmelos-mediated zinc oxide nanoparticles for mosquito control, cancer therapy, and antibacterial applications.余甘子介导的氧化锌纳米颗粒在蚊虫控制、癌症治疗及抗菌应用中的研究
Bioprocess Biosyst Eng. 2025 Apr 28. doi: 10.1007/s00449-025-03162-0.
5
Effective approaches in conquering chemoresistance of glioblastoma: potential for nanoformulations.攻克胶质母细胞瘤化学抗性的有效方法:纳米制剂的潜力
Drug Deliv Transl Res. 2025 Apr 21. doi: 10.1007/s13346-025-01859-z.
6
The atypical KRAS mutation directs TGF-β response towards partial epithelial-to-mesenchymal transition in patient-derived colorectal cancer tumoroids.非典型KRAS突变使患者来源的结直肠癌类肿瘤中转化生长因子-β反应趋向于部分上皮-间质转化。
Mol Oncol. 2025 Aug;19(8):2212-2232. doi: 10.1002/1878-0261.70014. Epub 2025 Mar 11.
7
Carrier-Free Cisplatin-Dactolisib Nanoparticles for Enhanced Synergistic Antitumor Efficacy.用于增强协同抗肿瘤疗效的无载体顺铂-达可替尼纳米颗粒
ACS Biomater Sci Eng. 2025 Mar 10;11(3):1456-1471. doi: 10.1021/acsbiomaterials.4c00672. Epub 2025 Feb 24.
8
Exploring the Role of Epithelial-Mesenchymal Transcriptional Factors Involved in Hematological Malignancy and Solid Tumors: A Systematic Review.探索上皮-间质转录因子在血液系统恶性肿瘤和实体瘤中的作用:一项系统综述
Cancers (Basel). 2025 Feb 5;17(3):529. doi: 10.3390/cancers17030529.
9
PAX6 enhances Nanog expression by inhibiting NOTCH signaling to promote malignant properties in small cell lung cancer cells.PAX6通过抑制NOTCH信号通路增强Nanog表达,从而促进小细胞肺癌细胞的恶性特性。
Heliyon. 2025 Jan 10;11(2):e41795. doi: 10.1016/j.heliyon.2025.e41795. eCollection 2025 Jan 30.
10
Promoter hypermethylation-mediated downregulation of PAX6 promotes tumor growth and metastasis during the progression of liver cancer.启动子超甲基化介导的 PAX6 下调促进肝癌进展过程中的肿瘤生长和转移。
Clin Epigenetics. 2024 Nov 29;16(1):174. doi: 10.1186/s13148-024-01789-6.
Src 通过激活 AKT 上调 ZEB1 和 ZEB2 促进表皮生长因子诱导的胃癌细胞上皮间质转化和迁移。
Cell Biol Int. 2018 Mar;42(3):294-302. doi: 10.1002/cbin.10894. Epub 2017 Nov 15.
4
NatD promotes lung cancer progression by preventing histone H4 serine phosphorylation to activate Slug expression.N-乙酰转移酶D通过阻止组蛋白H4丝氨酸磷酸化以激活Slug表达来促进肺癌进展。
Nat Commun. 2017 Oct 13;8(1):928. doi: 10.1038/s41467-017-00988-5.
5
FKBP3 Promotes Proliferation of Non-Small Cell Lung Cancer Cells through Regulating Sp1/HDAC2/p27.FKBP3通过调控Sp1/HDAC2/p27促进非小细胞肺癌细胞增殖。
Theranostics. 2017 Jul 22;7(12):3078-3089. doi: 10.7150/thno.18067. eCollection 2017.
6
Simultaneous overactivation of Wnt/β-catenin and TGFβ signalling by miR-128-3p confers chemoresistance-associated metastasis in NSCLC.miR-128-3p 通过同时激活 Wnt/β-catenin 和 TGFβ 信号通路赋予 NSCLC 化疗耐药相关转移能力。
Nat Commun. 2017 Jun 19;8:15870. doi: 10.1038/ncomms15870.
7
The Cdc42/Rac1 regulator CdGAP is a novel E-cadherin transcriptional co-repressor with Zeb2 in breast cancer.Cdc42/Rac1调节因子CdGAP是一种在乳腺癌中与Zeb2共同作用的新型E-钙黏蛋白转录共抑制因子。
Oncogene. 2017 Jun 15;36(24):3490-3503. doi: 10.1038/onc.2016.492. Epub 2017 Jan 30.
8
HPIP expression predicts chemoresistance and poor clinical outcomes in patients with epithelial ovarian cancer.HPIP表达可预测上皮性卵巢癌患者的化疗耐药性及不良临床预后。
Hum Pathol. 2017 Feb;60:114-120. doi: 10.1016/j.humpath.2016.10.015. Epub 2016 Nov 4.
9
The ERK-ZEB1 pathway mediates epithelial-mesenchymal transition in pemetrexed resistant lung cancer cells with suppression by vinca alkaloids.ERK-ZEB1通路介导培美曲塞耐药肺癌细胞的上皮-间质转化,长春花生物碱可对其产生抑制作用。
Oncogene. 2017 Jan 12;36(2):242-253. doi: 10.1038/onc.2016.195. Epub 2016 Jun 6.
10
Prolonged pemetrexed pretreatment augments persistence of cisplatin-induced DNA damage and eliminates resistant lung cancer stem-like cells associated with EMT.培美曲塞长期预处理可增强顺铂诱导的DNA损伤的持续性,并消除与上皮-间质转化相关的耐药肺癌干细胞样细胞。
BMC Cancer. 2016 Feb 19;16:125. doi: 10.1186/s12885-016-2117-4.